Chevening Scholarship 2026: Applications will be accepted from August 5, 2025, until October 7, 2025, for the 2025–2026 academic year. By June 2026, it should be completed. The rigorous selection ...
NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback